ACMR

ACM Research, Inc. Class A · NASDAQ

$52.86USDCS band Mixed

↑ $0.89 (1.70%) Today

As of Oct 28, 12:14 PM ET · May be delayed

Sign up free to see this.

Daily prices
Mkt Cap
$3.7B
Volume
675K
52W High
$127.19
52W Low
$28.46
PE Ratio
24.5
Avg Vol
1.2M
As of 10/27/26
Div Yield
—
Beta
3.58
As of 10/27/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about ACMR?

Latest news

News ›

Zacks Investment Research

ACM Research, Inc. (ACMR) Stock Drops Despite Market Gains: Important Facts to Note

ACM Research (ACMR) closed down 2.01% to $54.96, underperforming the broader market despite the S&P 500 gaining 0.28%. The stock has declined 22.92% over the past month, significantly lagging the Computer and Technology sector.

Zacks Investment Research

ACM Research, Inc. (ACMR) is Attracting Investor Attention: Here is What You Should Know

ACM Research (ACMR) has attracted investor attention despite a -22.9% stock decline over the past month. The company shows strong fundamentals with expected earnings growth of +41.7% for the current quarter and +27.3% for the fiscal year.

Zacks Investment Research

ACM Research, Inc. (ACMR) Registers a Bigger Fall Than the Market: Important Facts to Note

ACM Research (ACMR) fell 4.58% to $68.10, underperforming the S&P 500's 0.06% loss. Despite the recent decline, the company is projected to report strong earnings growth of 41.67% year-over-year with revenue expected to rise 14.8%. The stock holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 34.81, in line with industry averages.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.